AsortinoBeta
ICON plc logo

ICLRICON plc

NASDAQStockHealthcareDiagnostics & Research🇮🇪 IrelandISIN IE0005711209iconplc.com
$164.85+0.78%
NASDAQ · at close Sep 4, 2026
Tokenized by
Reality logo
1 issuerOn
Arbitrum One logoMorph logo
2 chains

Chart data are delayed by 15 minutes.

1D+0.78%
1M+5.10%
3M+7.89%
1Y6.53%
3Y37.25%
5Y37.17%

Main metrics

$12.72B
257.58
$0.64
716.5K
1.20
$66.5752-week range$203.91

About ICLR

ICON plc is a clinical research organisation that provides outsourced drug and device development services to pharmaceutical, biotechnology, medical device, and public health customers. The company supports clinical development across the full product lifecycle, including study design, trial management, data solutions, site and patient access, laboratory services, and commercialization support. ICON plc also offers consulting and advisory capabilities, decentralized and hybrid trial services, real-world intelligence, and therapeutic expertise across areas such as oncology, cardiology, infectious disease, immunology, and central nervous system disorders. Its work is used to help clients run clinical programs more efficiently and bring medical treatments through development and approval pathways. Headquartered in Dublin, Ireland, ICON plc operates through a broad international network and serves organizations in multiple global markets.

Similar products

Wuxi XDC Cayman Inc. logo
2268HKEX
HK$72.550.34%
Wuxi XDC Cayman Inc.
Backed Finance logo
1 issuer · 10 chains
Agilent Technologies Inc. logo
ANYSE
$150.86+0.59%
Agilent Technologies Inc.
Backed Finance logoReality logoDinari Inc. logo
3 issuers · 13 chains
Charles River Laboratories International, Inc. logo
CRLNYSE
$288.501.65%
Charles River Laboratories International, Inc.
Reality logoDinari Inc. logo
2 issuers · 6 chains
Quest Diagnostics Incorporated logo
DGXNYSE
$237.140.94%
Quest Diagnostics Incorporated
Backed Finance logoReality logoDinari Inc. logo
3 issuers · 14 chains